CN Stock MarketDetailed Quotes

605116 Aurisco Pharmaceutical

Watchlist
  • 22.32
  • +0.07+0.31%
Not Open Aug 28 15:00 CST
9.07BMarket Cap23.72P/E (TTM)

Aurisco Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aurisco Pharmaceutical Q2 2024 Earnings Date

Currency：CNYAug 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
395.03M
--
+57.69%
Net Income
--
106.41M
--
+108.08%
Analyst Rating
Strong Buy

Aug 28, 2024

Aurisco Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.067B--
--2024/FY-- / 1.626B--
--2023/FY1.263B / 1.322B--
--2022/FY1.008B / 1.056B--
--2021/FY803.363M / 819.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 2.067B--
--2024/FY-- / 1.626B--
--2023/FY1.263B / 1.322B--
--2022/FY1.008B / 1.056B--
--2021/FY803.363M / 819.000M--

Unlock Free Earnings Estimates

Aurisco Pharmaceutical Earnings Reports

  • Orient Pharmaceutical Co., Ltd. 2024 Semi-Annual Report

    12:00 ET

  • Summary of the 2024 semi-annual report of Orient Pharmaceutical Co., Ltd.

    12:00 ET

  • Announcement of aurisco pharmaceutical's expected performance increase in the first half of 2024.

    Jul 9 12:00 ET

  • Summary of the 2023 Annual Report of Orient Pharmaceutical Co., Ltd.

    Apr 28 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 28, 2024

    Strong Buy

    • Strong Buy

      60.00%

    • Buy

      40.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg